{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:41:12Z","timestamp":1791110472304,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T12:17:14Z","timestamp":1389701834000},"page":"578-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy"],"prefix":"10.1016","volume":"132","author":[{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela E.","family":"McGree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah","family":"Jatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbie S.","family":"Gostout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl C.","family":"Podratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.1999.5688","article-title":"Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer","volume":"76","author":"Mariani","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2005.07.014","article-title":"Resection of lymph node metastases influences survival in stage IIIC endometrial cancer","volume":"99","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2006.01.032","article-title":"Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients","volume":"101","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.01.007_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bjc.6603898","article-title":"The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients","volume":"97","author":"Chan","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2006.10.013","article-title":"Endometrial cancer: revisiting the importance of pelvic and para aortic lymph nodes","volume":"104","author":"Aalders","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"23","key":"10.1016\/j.ygyno.2014.01.007_bb0035","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"9658","key":"10.1016\/j.ygyno.2014.01.007_rf0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"issue":"9677","key":"10.1016\/j.ygyno.2014.01.007_rf0215","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(09)60983-1","volume":"373","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0050","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"129","author":"Ayeni","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2014.01.007_bb0055","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","article-title":"Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy","volume":"75","author":"Onda","year":"1997","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1999.5569","article-title":"FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy","volume":"75","author":"Nelson","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.01.007_bb0065","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0360-3016(01)01590-5","article-title":"Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma","volume":"50","author":"Mundt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0070","first-page":"201","article-title":"Analysis of failures in patients with FIGO stage IIIc1\u2013IIIc2 endometrial cancer","volume":"32","author":"Gadducci","year":"2012","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2012.10.010","article-title":"A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer","volume":"128","author":"Secord","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2009.04.013","article-title":"FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes","volume":"114","author":"Hoekstra","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.06.035","article-title":"Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation","volume":"115","author":"Klopp","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2012.06.026","article-title":"Combined chemotherapy and radiation improves survival for node-positive endometrial cancer","volume":"127","author":"Lee","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygyno.2005.12.010","article-title":"Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer","volume":"102","author":"Takeshima","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.01.007_bb0105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/IGC.0b013e3181d80aff","article-title":"Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma","volume":"20","author":"Hiura","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2012.02.003","article-title":"A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer","volume":"125","author":"Scribner","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6157","article-title":"Analysis of FIGO stage IIIc endometrial cancer patients","volume":"81","author":"McMeekin","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2009.12.021","article-title":"Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status","volume":"149","author":"Fotopoulou","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0360-3016(92)90676-9","article-title":"Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma","volume":"24","author":"Rose","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/gyno.2001.6278","article-title":"Nodal distribution and its significance in FIGO stage IIIc endometrial cancer","volume":"82","author":"McMeekin","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Gynecologic Oncology Group study. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Japanese Gynecologic Oncology Group. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ygyno.2014.01.007_bb0150","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer: results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ygyno.2011.05.018","article-title":"Adjuvant treatment for stage IIIC endometrial cancer: options and controversies","volume":"122","author":"Shah","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.01.007_bb0160","series-title":"Histological typing of female genital tract tumours","first-page":"13","year":"1994"},{"key":"10.1016\/j.ygyno.2014.01.007_bb0165","first-page":"125","article-title":"Definition of the clinical stages in carcinoma of the vulva","volume":"35","author":"FIGO stages: 1988 revision","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_rf0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ygyno.2014.01.007_rf0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijgo.2009.08.009","volume":"108","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.137.1.20","article-title":"The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs","volume":"137","author":"Khuri","year":"2002","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3181b4148f","article-title":"Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals","volume":"250","author":"Hall","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ygyno.2014.01.007_bb0185","volume":"144.295","author":"Disclosure of health records for external research","year":"2012","journal-title":"Minn Rev Stat"},{"issue":"4","key":"10.1016\/j.ygyno.2014.01.007_bb0190","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"9213","key":"10.1016\/j.ygyno.2014.01.007_bb0195","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomised trial. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_rf0320","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_rf0325","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2004.04.002","volume":"94","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.01.007_bb0205","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"PORTEC Study Group. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9658","key":"10.1016\/j.ygyno.2014.01.007_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"ASTEC\/EN.5 study group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2014.01.007_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2009.10.043","article-title":"Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence","volume":"116","author":"Rasool","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:54:29Z","timestamp":1648040069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814000183"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}